Armeniaspirol B

Armeniaspirol B is a selective antibiotic targeting Gram-positive pathogens, showing MIC values of 0.5 μg/mL against S. aureus Newman and 2.0 μg/mL against S. aureus USA300. Armeniaspirol B is promising for research of Gram-positive bacterial infections (e.g., MRSA, VRE infections) [1].

Product Specifications

CAS Number

[1206881-48-2]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Smiles

O=C1[C@]2(C(Cl)=C(C(N2C)=O)Cl)OC3=C(CCCC(C)C)C(O)=CC=C31

Molecular Formula

C18H19Cl2NO4

Molecular Weight

384.25

References & Citations

[1]Qiao Y, et al. Characterization of the Biosynthetic Gene Cluster for the Antibiotic Armeniaspirols in Streptomyces armeniacus. J Nat Prod. 2019 Feb 22;82 (2) :318-323.